Silence Therapeutics PLC Holding(s) in Company (7333I)
December 15 2020 - 6:28AM
UK Regulatory
TIDMSLN
RNS Number : 7333I
Silence Therapeutics PLC
15 December 2020
TR-1: Standard form for notification of major holdings
1a. Identity of the issuer or the underlying
issuer of existing shares to which voting Silence Therapeutics Plc
rights are at- tached ii :
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
------------------
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights
------------------
An acquisition or disposal of financial instruments
------------------
An event changing the breakdown of voting rights X
------------------
Other (please specify)(iii) :
------------------
3 . D e t a i ls of p ers on s ub j ect to t he no t i f i c a t i on
ob li g a t i on iv
Name Robert Quested
------------------------------------------------------------------
City and country of registered office
(if applicable)
------------------------------------------------------------------
4 . Fu ll n ame of s h are hold er( s) (i f d i f f e r e nt f r om 3.
) v
Name
------------------------------------------------------------------
City and country of registered office
(if applicable)
------------------------------------------------------------------
5. Date on which the threshold was 10(th) December 2020
crossed or reached vi :
------------------------------------------------------------------
6. Date on which issuer notified 14(th) December 2020
(DD/MM/YYYY):
------------------------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting rights % of voting rights Total number
at- tached to through financial Total of both of voting rights
shares (to- tal instru- ments in % (8.A + 8.B) of is- suer
of 8. A) (total of 8.B 1 vii
+ 8.B 2)
---------------------- ---------------------- ---------------------- ------------------
Resulting situation
on the date on
which threshold
was
crossed or reached 9.52% 83,306,259
---------------------- ---------------------- ---------------------- ------------------
Position of previous
notification (if
applicable) 10.72%
---------------------- ---------------------- ---------------------- ------------------
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of Number of voting rights ix % of voting rights
--------------------------------------------------- ------------------------------------------------------
shares Direct Indirect Direct Indirect
ISIN code (if (Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
possible)
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1)
(DTR5.2.1) (DTR5.2.1)
------------------------ ------------------------- --------------------------- -------------------------
GB00B9GTXM62 7,930,279 0 9.52% 0.00%
------------------------ ------------------------- --------------------------- -------------------------
SUBTOTAL 8. A 7,930,279 9.52%
--------------------------------------------------- ------------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Number of voting
Type of financial Expiration Exercise/ Conversion rights that may be % of voting rights
in- strument date x Period xi acquired if the instrument
is exercised/converted.
------------- ----------------------- ---------------------------- ---------------------
SUBTOTAL 8. B 1
----------------------- ---------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to Art.
13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial Expiration Exercise/ Physical or Number of
instrument date x Conversion cash settlement voting rights % of voting rights
Pe- riod xi xii
----------- ------------- ----------------- --------------- ---------------------
SUBTOTAL 8.B.2
----------------- --------------- ---------------------
9. Information in relation to the person subject to the notification
obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by
any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the (underlying)
issuer(xiii)
----------------------------
Full chain of controlled undertakings through which the voting rights
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity(xiv) (please add additional
rows as necessary)
----------------------------
% of voting rights % of voting rights Total of both if
if it equals or is through financial it equals or is higher
N a me xv higher than the notifiable in- struments if than the notifiable
threshold it equals or is higher threshold
than the
notifiable threshold
---------------------------------- ----------------------------- ------------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights
will be held
Place of completion UK
Date of completion 14(th) December 2020
---------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUVUURRAUUAAA
(END) Dow Jones Newswires
December 15, 2020 07:28 ET (12:28 GMT)
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Apr 2023 to Apr 2024
Real-Time news about Silence Therapeutics Plc (London Stock Exchange): 0 recent articles
More Silence Therapeutics Plc News Articles